Australia markets closed

Harvard Bioscience, Inc. (HBIO)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
2.5300+0.2100 (+9.05%)
At close: 04:00PM EDT
2.5100 -0.02 (-0.79%)
Pre-market: 08:00AM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
101,125
112,250
113,335
118,904
102,100
Cost of revenue
42,083
46,179
52,516
51,252
44,059
Gross profit
59,042
66,071
60,819
67,652
58,041
Operating expenses
Research development
11,421
11,764
12,329
10,799
8,685
Selling general and administrative
45,993
46,888
49,534
48,947
43,425
Total operating expenses
62,826
64,177
67,985
65,586
57,820
Operating income or loss
-3,784
1,894
-7,166
2,066
221
Interest expense
3,176
3,591
2,548
1,540
4,831
Total other income/expenses net
-2,469
-859
535
-666
-2,682
Income before tax
-9,429
-2,556
-9,179
-140
-7,292
Income tax expense
1,249
859
337
148
518
Income from continuing operations
-10,678
-3,415
-9,516
-288
-7,810
Net income
-10,678
-3,415
-9,516
-288
-7,810
Net income available to common shareholders
-10,678
-3,415
-9,516
-288
-7,810
Basic EPS
-0.01
-0.08
-0.23
-0.01
-0.20
Diluted EPS
-0.01
-0.08
-0.23
-0.01
-0.20
Basic average shares
40,343
42,420
41,413
40,343
38,640
Diluted average shares
40,343
42,420
41,413
40,343
38,640